ctrl K

Watchlist Price Alert

Albany Molecular Research... (AMRI)

NASDAQ: AMRI · Real-Time Price · USD

undefined

null (null%)

At close: Jun 28, 2019, 10:07 PM

Albany Molecular Research Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2016
Period Ending	Dec 31, 2016
Revenue	570.45M
Cost of Revenue	437.65M
Gross Profit	132.8M
Operating Income	-18.76M
Interest Income	n/a
Pretax Income	-59.96M
Net Income	-70.17M
Selling & General & Admin	122.14M
Research & Development	16.05M
Other Expenses	n/a
Operating Expenses	138.18M
Interest Expense	39.92M
Selling & Marketing Expenses	n/a
Cost & Expenses	589.21M
Income Tax Expense	10.21M
Shares Outstanding (Basic)	42.45M
Shares Outstanding (Diluted)	42.45M
EPS (Basic)	-1.65
EPS (Diluted)	-1.65
EBITDA	36.67M
EBIT	-20.04M
Depreciation & Amortization	56.71M